Showing results (171-180 of 262) with videos related to
Sort By:
Pageof 27
Blood|December 31, 1997
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B studyK Mrózek, K Heinonen, D Lawrence, et al.Vascular Medicine (London, England)|September 9, 2024
Trends in patient characteristics and mortality among Medicare patients diagnosed with peripheral artery diseaseXavier Fowler, Kunal Mehta, Mark Eid, et al.Blood|May 1, 1996
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapyI Tepler, L Elias, J W Smith, et al.Circulation. Cardiovascular Quality and Outcomes|June 20, 2023
Trends of Concomitant Diabetes and Peripheral Artery Disease and Lower Extremity Amputation in US Medicare Patients, 2007 to 2019Xavier P Fowler, Mark A Eid, J Aaron Barnes, et al.International Journal of Oncology|October 9, 2002
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461Sherif S Farag, Kellie J Archer, Krzysztof Mrózek, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III studyJorge Cortes, Joseph O Moore, Richard T Maziarz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemiaDavid A Rizzieri, Adam J Bass, Gary L Rosner, et al.Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.The American Journal of Cardiology|November 15, 2016
Comparison of Outcomes of Operative Therapy for Acute Type A Aortic Dissections Provided at High-Volume Versus Low-Volume Medical Centers in North TexasMani Arsalan, John J Squiers, Morley A Herbert, et al.Cancer|May 26, 2004
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaDavid A Rizzieri, Gregory J Sand, Dean McGaughey, et al.Pageof 27